Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2800 of 3173 entries
View as:

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05675449 Org: User:
Start: 12/14/22 End: 02/29/28 Due: 02/28/29

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase: N/A Priority: Normal
NCT ID: NCT06679140 Org: User:
Start: 12/08/24 End: 05/06/27 Due: 05/06/28

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05623020 Org: User:
Start: 11/10/22 End: 11/29/31 Due: 11/29/32

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Phase: N/A Priority: Normal
NCT ID: NCT06152575 Org: User:
Start: 02/08/24 End: 12/30/27 Due: 12/30/28

A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06140290 Org: User:
Start: 12/20/23 End: 03/01/24 Due: 03/01/25

Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01927341 Org: User:
Start: 11/19/13 End: 01/25/16 Due: 01/25/17

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05156398 Org: User:
Start: 02/28/22 End: 11/27/32 Due: 11/27/33

A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06003777 Org: User:
Start: 08/30/23 End: 02/20/24 Due: 02/20/25

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

Phase: N/A Priority: Normal
NCT ID: NCT06462235 Org: User:
Start: 09/25/24 End: 07/31/28 Due: 07/31/29

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Phase: N/A Priority: Normal
NCT ID: NCT05020236 Org: User:
Start: 10/04/21 End: 05/31/27 Due: 05/31/28

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Phase: N/A Priority: Normal
NCT ID: NCT07013474 Org: User:
Start: 07/10/25 End: 05/06/27 Due: 05/06/28

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00798707 Org: User:
Start: 12/31/08 End: 04/30/10 Due: 04/30/11

6-week Safety and PD Study in Adults With NAFLD

Phase: N/A Priority: Normal
NCT ID: NCT03256526 Org: User:
Start: 09/27/17 End: 04/27/18 Due: 04/27/19

A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)

Phase: N/A Priority: Normal
NCT ID: NCT01953731 Org: User:
Start: 10/31/13 End: 01/31/14 Due: 01/31/15

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00174486 Org: User:
Start: 02/28/05 End: 06/30/05 Due: 06/30/06

A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03121664 Org: User:
Start: 04/07/17 End: 09/14/17 Due: 09/14/18

Long Term Study With B2036-PEG

Phase: N/A Priority: Normal
NCT ID: NCT00143416 Org: User:
Start: 04/30/04 End: 07/31/07 Due: 07/31/08

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04176354 Org: User:
Start: 01/25/19 End: 09/27/19 Due: 09/27/20

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00521586 Org: User:
Start: 09/30/07 End: 12/31/13 Due: 12/31/14

PF-07284892 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04800822 Org: User:
Start: 03/17/21 End: 06/19/24 Due: 06/19/25

STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS

Phase: N/A Priority: Normal
NCT ID: NCT04635631 Org: User:
Start: 11/30/20 End: 12/14/21 Due: 12/14/22

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

Phase: N/A Priority: Normal
NCT ID: NCT00916617 Org: User:
Start: 06/30/09 End: 09/30/12 Due: 09/30/13

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Phase: N/A Priority: Normal
NCT ID: NCT02297438 Org: User:
Start: 03/23/15 End: 02/28/25 Due: 02/28/26

An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01793285 Org: User:
Start: 12/31/10 End: 02/29/12 Due: 02/28/13

Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00424632 Org: User:
Start: 11/30/06 End: 06/30/09 Due: 06/30/10